Page last updated: 2024-11-01

nortriptyline and Cochlear Hearing Loss

nortriptyline has been researched along with Cochlear Hearing Loss in 2 studies

Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.

Research Excerpts

ExcerptRelevanceReference
"Our hypothesis was that adjuvant migraine medications may improve outcomes in SSNHL."1.62Adjuvant Migraine Medications in the Treatment of Sudden Sensorineural Hearing Loss. ( Abouzari, M; Chua, JT; Djalilian, HR; Goshtasbi, K; Lin, HW; Saber, T; Sarna, B; Tan, D, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abouzari, M1
Goshtasbi, K1
Chua, JT1
Tan, D1
Sarna, B1
Saber, T1
Lin, HW1
Djalilian, HR1
Sullivan, M1
Katon, WJ1
Russo, J1
Dobie, R1
Sakai, C1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss[NCT05403229]Phase 2140 participants (Anticipated)Interventional2022-10-17Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for nortriptyline and Cochlear Hearing Loss

ArticleYear
Somatization, co-morbidity, and the quality of life: measuring the effect of depression upon chronic medical illness.
    Psychiatric medicine, 1992, Volume: 10, Issue:3

    Topics: Activities of Daily Living; Audiometry, Pure-Tone; Chronic Disease; Comorbidity; Depressive Disorder

1992

Other Studies

1 other study available for nortriptyline and Cochlear Hearing Loss

ArticleYear
Adjuvant Migraine Medications in the Treatment of Sudden Sensorineural Hearing Loss.
    The Laryngoscope, 2021, Volume: 131, Issue:1

    Topics: Administration, Oral; Adult; Aged; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids

2021